Important NoticeThis app is for educational purposes only. You must be 18+ to use it. We do not sell any peptides on this site.

Peptide Library / Detail
Half-life
Not fully characterized; depends on delivery method
Delivery
Topical application via hydrogel patches or transdermal formulations
Dosage
—
Research Use Only
All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.
PTD-DBM is a cell-penetrating peptide designed to inhibit CXXC5, a negative regulator of Wnt/β-catenin signaling. By blocking the interaction between CXXC5 and Dishevelled (Dvl), it promotes activation of Wnt pathways critical for hair follicle regeneration and wound healing. This peptide has shown promise in preclinical research for treating androgenetic alopecia and enhancing tissue repair.
Typically applied topically in research settings via hydrogel patches or other delivery systems. Experimental protocols have used combination therapy approaches with controlled-release formulations. Dosing and frequency vary by delivery method and remain under investigation in clinical trials.
PTD-DBM contains a protein transduction domain (PTD) fused to a Dishevelled-binding motif (DBM) that competitively inhibits CXXC5 binding to Dishevelled proteins. This inhibition prevents CXXC5 from suppressing Wnt/β-catenin signaling, thereby promoting dermal papilla cell proliferation, hair follicle neogenesis, and enhanced wound healing through reconstruction of the regenerative microenvironment.
PTD-DBM is a cell-penetrating peptide designed to inhibit CXXC5, a negative regulator of Wnt/β-catenin signaling. By blocking the interaction between CXXC5 and Dishevelled (Dvl), it promotes activation of Wnt pathways critical for hair follicle regeneration and wound healing. This peptide has shown promise in preclinical research for treating androgenetic alopecia and enhancing tissue repair.
PTD-DBM has an approximate half-life of Not fully characterized; depends on delivery method. The half-life determines how often you need to inject to maintain steady blood levels — use the Peptides Calculator half-life calculator to plot your specific dosing schedule and see the decay curve.
PTD-DBM is typically delivered via topical application via hydrogel patches or transdermal formulations. The Peptides Calculator app helps you reconstitute the vial with bacteriostatic water, calculate your exact dose in syringe units, and track each injection.
PTD-DBM contains a protein transduction domain (PTD) fused to a Dishevelled-binding motif (DBM) that competitively inhibits CXXC5 binding to Dishevelled proteins. This inhibition prevents CXXC5 from suppressing Wnt/β-catenin signaling, thereby promoting dermal papilla cell proliferation, hair follicle neogenesis, and enhanced wound healing through reconstruction of the regenerative microenvironment.
Studied benefits of PTD-DBM include: Promotes hair follicle regeneration and neogenesis, Activates Wnt/β-catenin signaling pathways, Accelerates cutaneous wound healing, Counteracts DHT-mediated effects in androgenetic alopecia, Enhances dermal papilla cell proliferation, Supports reconstruction of regenerative tissue microenvironment, May improve hair density and thickness in pattern baldness. These are research findings only — Peptides Calculator does not provide medical advice; consult a qualified healthcare professional before starting any peptide protocol.
Reported side effects of PTD-DBM include: Localized skin irritation at application site, Potential allergic reactions to peptide or delivery vehicle, Unknown long-term safety profile in humans, Possible inflammation at treatment area, Effects on systemic Wnt signaling unknown. Always discuss potential side effects with a licensed healthcare provider before using any research peptide.
Other skin/hair compounds in the Peptides Calculator library.
Half-life · Not well-characterized; topical applications show local tissue retention
Half-life · Not well established; topical formulations typically remain active for 8-12 hours
Half-life · Not applicable for topical application; cellular effects persist 24-48 hours
Half-life · Approximately 4-6 hours when applied topically, with variable absorption dependent on formulation vehicle and skin condition
Half-life · Not applicable for topical application
Half-life · Varies by formulation; topical application provides sustained release over several hours